Salicylic Acid-d4
(Synonyms: 水杨酸-D4) 目录号 : GC49480An internal standard for the quantification of salicylic acid
Cas No.:78646-17-0
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Salicylic acid-d4 is intended for use as an internal standard for the quantification of salicylic acid by GC- or LC-MS. Salicylic acid is an active metabolite of the COX inhibitor aspirin and a plant hormone that has been found in Cucumis sativus.1,2 It protects Cucumis sativus leaves from infection by S. fuliginea or E. cichoracearum when used at a concentration of 10 mM, as well as inhibits A. thaliana root growth at 0.3 mM.2,3 Salicylic acid (1 and 4 mM) reduces IFN-γ- and TNF-α-induced increases in NOS2 expression in primary rat cardiac fibroblasts.4 It decreases urine prostaglandin E2 levels in dogs when administered at a dose of 40 mg/kg.5
1.Klessig, D.F.Newly identified targets of aspirin and its primary metabolite, salicylic acidDNA Cell Biol.35(4)163-166(2016) 2.Feussner, I., Fritz, I.G., Hause, B., et al.Induction of a new lipoxygenase form in cucumber leaves by salicylic acid or 2,6-dichloroisonicotinic acidBot. Acta110(2)101-108(1997) 3.Kim, T.-H., Kunz, H.-H., Bhattacharjee, S., et al.Natural variation in small molecule-induced TIR-NB-LRR signaling induces root growth arrest via EDS1- and PAD4-complexed R protein VICTR in ArabidopsisPlant Cell24(12)5177-5192(2012) 4.Farivar, R.S., and Brecher, P.Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblastsJ. Biol. Chem.271(49)31585-31592(1996) 5.Zambraski, E.J., Atkinson, D.C., and Diamond, J.Effects of salicylate vs. aspirin on renal prostaglandins and function in normal and sodium-depleted dogsJ. Pharmacol. Exp. Ther.247(1)96-103(1988)
Cas No. | 78646-17-0 | SDF | Download SDF |
别名 | 水杨酸-D4 | ||
Canonical SMILES | OC(C1=C(C([2H])=C([2H])C([2H])=C1[2H])O)=O | ||
分子式 | C7H2D4O3 | 分子量 | 142.1 |
溶解度 | DMSO: soluble | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 7.0373 mL | 35.1865 mL | 70.373 mL |
5 mM | 1.4075 mL | 7.0373 mL | 14.0746 mL |
10 mM | 0.7037 mL | 3.5186 mL | 7.0373 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。